Vulnerability Description
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Insulet | Omnipod Insulin Management System Firmware | - |
| Insulet | Omnipod Insulin Management System | 19191 |
Related Weaknesses (CWE)
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01Third Party AdvisoryUS Government Resource
- https://www.myomnipod.com/security-bulletinsVendor Advisory
- https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01Third Party AdvisoryUS Government Resource
- https://www.myomnipod.com/security-bulletinsVendor Advisory
FAQ
What is CVE-2020-10627?
CVE-2020-10627 is a vulnerability with a CVSS score of 7.3 (HIGH). Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wir...
How severe is CVE-2020-10627?
CVE-2020-10627 has been rated HIGH with a CVSS base score of 7.3/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-10627?
Check the references section above for vendor advisories and patch information. Affected products include: Insulet Omnipod Insulin Management System Firmware, Insulet Omnipod Insulin Management System.